Ruggiero, R, Balzano, N, Nicoletti, MM, di Mauro, G, Fraenza, F, Campitiello, MR et al.. Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System. Pharmaceuticals (Basel). 2024;17 (3):. doi: 10.3390/ph17030394. PubMed PMID:38543180 PubMed Central PMC10974574.
Jakubowski, S, Kawalec, P, Holko, P, Kowalska-Bobko, I, Kamusheva, M, Petrova, G et al.. Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries. Front Pharmacol. 2024;15 :1369178. doi: 10.3389/fphar.2024.1369178. PubMed PMID:38523639 PubMed Central PMC10957562.
Liu, C, Liu, Y, Ou, L, Qi, Y, Zhang, J. Recent landscape and trends for industry-sponsored pediatric clinical trials in China from 2013 to 2022. Pediatr Investig. 2024;8 (1):12-20. doi: 10.1002/ped4.12409. PubMed PMID:38516137 PubMed Central PMC10951485.
Pandina, GJ, Busner, J, Kempf, L, Fallon, J, Alphs, LD, Acosta, MT et al.. Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group. Innov Clin Neurosci. 2024;21 (1-3):52-60. . PubMed PMID:38495603 PubMed Central PMC10941866.
Chen, X, Gao, M, Xia, Y, Wang, X, Qin, J, He, H et al.. Phase separation of Nur77 mediates XS561-induced apoptosis by promoting the formation of Nur77/Bcl-2 condensates. Acta Pharm Sin B. 2024;14 (3):1204-1221. doi: 10.1016/j.apsb.2023.11.017. PubMed PMID:38486987 PubMed Central PMC10935061.
Man, A, Groeneweg, GSS, Ross, CJD, Carleton, BC. The Role of Pharmacogenomics in Rare Diseases. Drug Saf. 2024; :. doi: 10.1007/s40264-024-01416-6. PubMed PMID:38483768 .
Kalland, ME, Pose-Boirazian, T, Palomo, GM, Naumann-Winter, F, Costa, E, Matusevicius, D et al.. Advancing rare disease treatment: EMA's decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation. Gene Ther. 2024; :. doi: 10.1038/s41434-024-00446-0. PubMed PMID:38480914 .
Vaghela, S, Tanni, KA, Banerjee, G, Sikirica, V. A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet J Rare Dis. 2024;19 (1):117. doi: 10.1186/s13023-024-03111-2. PubMed PMID:38475874 PubMed Central PMC10936002.
Weatherald, J, Sitbon, O. POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes. Chest. 2024;165 (3):492-494. doi: 10.1016/j.chest.2023.10.001. PubMed PMID:38461011 .
Awada, N, Holcik, M. Patient and family experiences of lysosomal storage diseases in Canada: A qualitative interview study. JIMD Rep. 2024;65 (2):63-84. doi: 10.1002/jmd2.12403. PubMed PMID:38444574 PubMed Central PMC10910218.
Guerrini, R, Chiron, C, Vandame, D, Linley, W, Toward, T. Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first-line add-on therapies for seizures in Dravet syndrome: A network meta-analysis. Epilepsia Open. 2024; :. doi: 10.1002/epi4.12923. PubMed PMID:38427284 .
Bouwman, L, Sepodes, B, Leufkens, H, Torre, C. Trends in orphan medicinal products approvals in the European Union between 2010-2022. Orphanet J Rare Dis. 2024;19 (1):91. doi: 10.1186/s13023-024-03095-z. PubMed PMID:38413985 PubMed Central PMC10900541.
Mease, C, Miller, KL, Fermaglich, LJ, Best, J, Liu, G, Torjusen, E et al.. Analysis of the first ten years of FDA's rare pediatric disease priority review voucher program: designations, diseases, and drug development. Orphanet J Rare Dis. 2024;19 (1):86. doi: 10.1186/s13023-024-03097-x. PubMed PMID:38403586 PubMed Central PMC10895788.
Chirmule, N, Feng, H, Cyril, E, Ghalsasi, VV, Choudhury, MC. Orphan drug development: Challenges, regulation, and success stories. J Biosci. 2024;49 :. . PubMed PMID:38383975 .
Clemente, T, Galli, L, Lolatto, R, Gagliardini, R, Lagi, F, Ferrara, M et al.. Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ Open. 2024;14 (2):e080606. doi: 10.1136/bmjopen-2023-080606. PubMed PMID:38341206 PubMed Central PMC10862296.
Csorba, A, Katona, G, Budai-Szűcs, M, Balogh-Weiser, D, Molnár, P, Maka, E et al.. A Comparative Pharmacokinetic Study for Cysteamine-Containing Eye Drops as an Orphan Topical Therapy in Cystinosis. Int J Mol Sci. 2024;25 (3):. doi: 10.3390/ijms25031623. PubMed PMID:38338900 PubMed Central PMC10855117.
Seoane-Vazquez, E, Rodriguez-Monguio, R, Powers, JH 3rd. Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980-2022. Sci Rep. 2024;14 (1):3325. doi: 10.1038/s41598-024-53554-7. PubMed PMID:38336899 PubMed Central PMC10858128.
Santoro, JD, Sico, JJ, Burke, JF, Sarkar, K, Turbes, M, Evans, DA et al.. Prescription Drug Prices: An AAN Position Statement. Neurology. 2024;102 (5):e209132. doi: 10.1212/WNL.0000000000209132. PubMed PMID:38335469 .
Lexchin, J. Therapeutic Value of Orphan Drugs Approved by Health Canada: A Cross-Sectional Study. J Gen Intern Med. 2024; :. doi: 10.1007/s11606-024-08651-8. PubMed PMID:38326584 .
Seror, R, Chiche, L, Beydon, M, Desjeux, G, Zhuo, J, Vannier-Moreau, V et al.. Estimated prevalence, incidence and healthcare costs of Sjögren's syndrome in France: a national claims-based study. RMD Open. 2024;10 (1):. doi: 10.1136/rmdopen-2023-003591. PubMed PMID:38307699 PubMed Central PMC10840052.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.